FRONT PAGE CONTRIBUTOR
State of the Race: Carly Fiorina (R CAND, CA-SEN).
I had the opportunity to talk with Carly yesterday on what is happening in the race right now. For those not following the Avastin controversy, it’s a cancer medication that is currently the target of a drive to have its FDA approval removed for last-stage breast cancer patients. Claims that this is primarily for financial reasons have been bolstered by this report from the BBC (via Hot Air) that the NHS is disallowing it for bowel cancer patients because it’s too expensive*. You can imagine how Carly feels about that… actually, you don’t have to imagine: you can listen to the interview.
Carly’s site is here.
*A little flub there on my part in the interview. Wishful thinking on it already being gone, you see.
Crossposted to Moe Lane.